NYSE - Delayed Quote • USD
Edwards Lifesciences Corporation (EW)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 24 | 24 | 29 | 28 |
| Avg. Estimate | 0.7 | 0.69 | 2.75 | 3.09 |
| Low Estimate | 0.67 | 0.66 | 2.65 | 2.88 |
| High Estimate | 0.72 | 0.7 | 2.8 | 3.24 |
| Year Ago EPS | 0.66 | 0.59 | 2.51 | 2.75 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 23 | 23 | 30 | 30 |
| Avg. Estimate | 1.64B | 1.61B | 6.52B | 7.15B |
| Low Estimate | 1.6B | 1.59B | 6.44B | 6.95B |
| High Estimate | 1.68B | 1.64B | 6.6B | 7.33B |
| Year Ago Sales | 1.5B | 1.48B | 6B | 6.52B |
| Sales Growth (year/est) | 9.30% | 9.00% | 8.50% | 9.80% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.65 | 0.59 | 0.64 | 0.64 |
| EPS Actual | 0.66 | 0.59 | 0.64 | 0.66 |
| Difference | 0.01 | 0 | 0 | 0.02 |
| Surprise % | 1.50% | 0.00% | 0.00% | 3.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.7 | 0.69 | 2.75 | 3.09 |
| 7 Days Ago | 0.7 | 0.69 | 2.75 | 3.09 |
| 30 Days Ago | 0.7 | 0.69 | 2.75 | 3.09 |
| 60 Days Ago | 0.7 | 0.69 | 2.75 | 3.09 |
| 90 Days Ago | 0.7 | 0.68 | 2.76 | 3.08 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EW | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 6.10% | -- | -- | 5.40% |
| Next Qtr. | 16.90% | -- | -- | 10.90% |
| Current Year | 9.60% | -- | -- | 4.50% |
| Next Year | 12.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 9.33% | -- | -- | 10.94% |
| Past 5 Years (per annum) | 9.81% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 4/26/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/26/2024 |
| Maintains | Stifel: Hold to Hold | 4/26/2024 |
| Maintains | Piper Sandler: Neutral to Neutral | 4/26/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 4/15/2024 |
| Maintains | Mizuho: Buy to Buy | 4/11/2024 |
Related Tickers
BSX Boston Scientific Corporation
73.17
-0.12%
DXCM DexCom, Inc.
124.34
-9.91%
MDT Medtronic plc
79.74
+0.62%
SYK Stryker Corporation
335.61
-0.46%
ALGN Align Technology, Inc.
309.02
-0.48%
PODD Insulet Corporation
166.19
+1.23%
SWAV Shockwave Medical, Inc.
330.00
+0.31%
ABT Abbott Laboratories
107.53
+0.63%
ITGR Integer Holdings Corporation
109.58
-1.41%
NARI Inari Medical, Inc.
38.42
+0.92%